January 4 CPE CPE Pharmacists increasing access to reproductive health care PT December 2022 People in the United States still struggle to access sexual and reproductive health care, as evidenced by the unintended pregnancy rate of 45%. Ashley H. Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCP
January 5 CPE CPE APhA pharmacy law matters: A year in review PT January 2023 Legislative, legal, and regulatory developments affecting pharmacy in 2022
February 7 CPE CPE Updates in heart failure management PT February 2023 Jason S. Haney, PharmD, BCPS, BCCCP
March 7 CPE CPE New therapeutic agents marketed in 2022: Part 1 PT March 2023 Four new therapeutic agents are considered in this review, the first in a series of articles on new therapeutic agents marketed in 2022: tirzepatide (Mounjaro–Eli Lilly and Company), daridorexant hydrochloride (Quviviq–Idorsia), tenapanor hydrochloride (Ibsrela–Ardelyx), and vonoprazan fumarate in co-packaging with amoxicillin, and amoxicillin and clarithromycin (Voquezna–Phathom Pharmaceuticals).